Sunshine Biopharma Inc. (SBFM) led the latest midday scan, gaining approximately 218.9%. The table below ranks the leading qualifying movers captured in the latest snapshot.
Top 10 Midday Movers
Scanner snapshot captured 2026-10-07T16:00:02.802Z.
| # | Ticker | Company | Move | Price | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | SBFM | Sunshine Biopharma Inc. | +218.9% | $1.27 | 74,860,435 | $1.7M |
| 2 | DKI | DarkIris Inc. | +128.7% | $3.11 | 24,503,740 | $2.9M |
| 3 | TOPP | Toppoint Holdings Inc. | +74.2% | $0.1944 | 491,081,594 | $4.8M |
| 4 | SXTC | China SXT Pharmaceuticals, Inc. | +70.0% | $2.13 | 59,146,040 | $2.8M |
| 5 | BIYA | Baiya International Group Inc. | +48.0% | $2.02 | 87,497,906 | $12.7M |
| 6 | FFR | FF EAI Robotics Ecosystem Inc. | +30.1% | $1.79 | 3,662,761 | $37.9M |
| 7 | NCPL | Netcapital Inc. | +28.9% | $1.41 | 4,201,255 | $11.0M |
| 8 | APUS | Apimeds Pharmaceuticals US, Inc. | +25.4% | $8.94 | 18,405,340 | $13.5M |
| 9 | GIPR | Generation Income Properties Inc. | +25.4% | $0.4771 | 132,717,773 | $1.4M |
| 10 | MI | NFT Limited | +24.5% | $1.53 | 31,054,719 | $936,038 |
What’s Driving the Moves
SBFM — Sunshine Biopharma Inc.
SBFM gained approximately 218.9% in the scanner snapshot. A possible catalyst was Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know. The headline should be verified against the original source before publication.
DKI — DarkIris Inc.
DKI gained approximately 128.7% in the scanner snapshot. A possible catalyst was DarkIris Advances Cine3.AI Global Rollout and Establishes U.S. Subsidiary for North American Expansion. The headline should be verified against the original source before publication.
TOPP — Toppoint Holdings Inc.
TOPP gained approximately 74.2% in the scanner snapshot. A possible catalyst was Toppoint Holdings Inc. Announces Anticipated Reincorporation from Nevada to Delaware. The headline should be verified against the original source before publication.
SXTC — China SXT Pharmaceuticals, Inc.
SXTC gained approximately 70.0% in the scanner snapshot. A possible catalyst was China SXT Pharmaceuticals, Inc. Announces Share Consolidation. The headline should be verified against the original source before publication.
BIYA — Baiya International Group Inc.
BIYA gained approximately 48.0% in the scanner snapshot. A possible catalyst was Baiya International Group Inc. Announces Reverse Split Record Date. The headline should be verified against the original source before publication.
FFR — FF EAI Robotics Ecosystem Inc.
FFR gained approximately 30.1% in the scanner snapshot. A possible catalyst was Faraday Future and FF EAI Robotics Ecosystem Inc. (Nasdaq: FFR) Jointly Address Key Investor Questions Regarding the Proposed Combination of FFAI's Robotics Business. The headline should be verified against the original source before publication.
NCPL — Netcapital Inc.
NCPL gained approximately 28.9% in the scanner snapshot. A possible catalyst was Netcapital Inc. Receives Nasdaq Notice Related to Delayed Quarterly Report on Form 10-Q. The headline should be verified against the original source before publication.
APUS — Apimeds Pharmaceuticals US, Inc.
APUS gained approximately 25.4% in the scanner snapshot. A possible catalyst was Why Is Apimeds Pharmaceuticals Stock Gaining Monday?. The headline should be verified against the original source before publication.
GIPR — Generation Income Properties Inc.
GIPR gained approximately 25.4% in the scanner snapshot. A possible catalyst was GIPR Announces Full Retirement of Loci Capital Financing Relationship. The headline should be verified against the original source before publication.
MI — NFT Limited
MI gained approximately 24.5% in the scanner snapshot. A possible catalyst was NFT Ltd. Announces Pricing of $2.55 Million Registered Direct Offering. The headline should be verified against the original source before publication.
What To Watch Next
Premarket and after-hours moves can reverse quickly. Editors should verify the catalyst, filing history, financing activity, float structure and liquidity before publication.
